Monoamine oxidase B gene and Cytochrome P450 2D6 gene polymorphism in sporadic Korean Parkinson's disease.
	    		
		   		
	    	
    	
    	
   		
        
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Yong Hee LEE
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Jeong Geun LIM
			        		
			        		;
		        		
		        		
		        		
			        		Sang Doe YI
			        		
			        		;
		        		
		        		
		        		
			        		Young Jae LEE
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. Department of Neurology, College of Medicine, Keimyung University, Dongsan Hospital, Taegu, Korea.
			        		
		        		
	        		
        		 
        	
        	
        	
        		- Publication Type:Original Article
 
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Parkinson's disease;
			        		
			        		
			        		
				        		Monoamine oxidase B;
			        		
			        		
			        		
				        		CYP2D6;
			        		
			        		
			        		
				        		Gene polymorphism
			        		
			        		
	        			
        			
        		
 
        	
            
            	- MeSH:
            	
	        			
	        				
	        				
				        		
					        		Alleles;
				        		
			        		
				        		
					        		Base Pairing;
				        		
			        		
				        		
					        		Cytochrome P-450 CYP2D6*;
				        		
			        		
				        		
					        		Cytochrome P-450 Enzyme System*;
				        		
			        		
				        		
					        		Cytochromes*;
				        		
			        		
				        		
					        		Debrisoquin;
				        		
			        		
				        		
					        		Digestion;
				        		
			        		
				        		
					        		DNA;
				        		
			        		
				        		
					        		Dopamine;
				        		
			        		
				        		
					        		Epidemiologic Studies;
				        		
			        		
				        		
					        		Exons;
				        		
			        		
				        		
					        		Genetic Predisposition to Disease;
				        		
			        		
				        		
					        		Humans;
				        		
			        		
				        		
					        		Introns;
				        		
			        		
				        		
					        		Male;
				        		
			        		
				        		
					        		Metabolism;
				        		
			        		
				        		
					        		Monoamine Oxidase*;
				        		
			        		
				        		
					        		Odds Ratio;
				        		
			        		
				        		
					        		Parkinson Disease*;
				        		
			        		
				        		
					        		Polymerase Chain Reaction;
				        		
			        		
				        		
					        		Polymorphism, Restriction Fragment Length
				        		
			        		
	        			
	        			
            	
            	
 
            
            
            	- From:Journal of the Korean Neurological Association
	            		
	            		 1999;17(1):63-71
	            	
            	
 
            
            
            	- CountryRepublic of Korea
 
            
            
            	- Language:Korean
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	BACKGROUND: Epidemiological studies have identified that positive family history and frequent exposures to environmental toxins such as 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) are of prime causative factors for PD. These toxins are mainly metabolized by MAO-B and CYP2D6. Thus, an individual with inherited defect in xenobiotic metabolism could have a higher susceptibility to PD. We performed this study to investigate a possible allelic association of MAO-B and CYP2D6 known to be involved in metabolism of dopamine and other drugs such as debrisoquine in PD. METHODS: We studied polymorphism of MAO-B and CYP2D6 genes in 69 sporadic idiopathic PD patients (31 males and 38 females) and 41 age-matched healthy control (20 males and 21 females) using genomic DNA extracted from peripheral blood white cell with polymerase chain reaction (PCR) amplification and restriction fragment length polymorphism (RFLP). RESULTS: There were eight different alleles of various numbers of GT repeats within the second intron of MAO-B. The frequency of (GT)20 allele was the highest (44.7%) in PD, while the frequencies of (GT)14 allele and (GT)19 allele were the highest in control groups. Furthermore, the odds ratios of (GT)16 allele and (GT)20 allele were 4.93 (95% confidence interval 0.6-107.63) and 6.15 (95% confidence interval; 2.52-15.51), respectively, suggesting a higher susceptibility to PD in (GT)20 allelic group (p<0.001). Polymorphism of CYP2D6 was also examined by PCR amplification followed by digestion with restriction enzymes. However, we were unable to identify G to A substitution at the junction of intron 3 and exon 4 nor base pair deletion in exon 5 from PD and control groups, which have been reported previously. CONCLUSIONS: These results suggest that the MAO-B gene polymorphism could serve as a determinant of genetic susceptibility to PD at least in Korean population. But the susceptibility may not be directly associated with polymorphism of CYP2D gene examined in this study.